OSPOMYVâ„¢ (denosumab-dssb) injection, for subcutaneous use Ospomyv is a RANK ligand (RANKL) inhibitor indicated for treatment: SELECTED SAFETY INFORMATION CONTRAINDICATIONS These highlights do ...
Another injection covered under Part D is denosumab. Denosumab is an injection that you get once every 6 months. This injection is covered by your Part D insurance plan and therefore is subject to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback